Close Bookmark and Share This Page

Save to Browser Favorites / Bookmarks

Ask backflip blinklist BlogBookmark Bloglines BlogMarks Blogsvine BuddyMarks BUMPzee! CiteULike Connotea del.icio.us

Digg diigo DotNetKicks DropJack dzone Facebook Fark Faves Friendsite folkd.com Furl Google

Jamespot Jeqq Kaboodle kirtsy linkaGoGo LinkedIn Ma.gnolia Mister Wong Mixx MySpace Netvouz Newsvine

oneview OnlyWire PlugIM Propeller Reddit Segnalo Shoutwire Simpy Slashdot Surphace Sphinn Spurl

Squidoo StumbleUpon Technorati ThisNext Twitter Webride Windows Live Yahoo!

Email This to a Friend

  Link HTML: 

 Permalink: 

 If you like this then please subscribe to the RSS Feed.

Powered by Bookmarkify™

More »

• Amgen Inc. (NASDAQ: AMGN) - Amgen is a top biotech stock that discovers, develops, and manufactures medicines based on advances in cellular and molecular biology. The company operates with a 31.84% profit margin and carries a forward P/E of 10.75. BUY Under $56.50 a share.

• Gilead Sciences (NASDAQ: GILD) – Gilead focuses on the research, development, and marketing of anti-infective medications with a focus on treatments for HIV. The company has a 38.35% profit margin and a forward P/E of 10.48. BUY Under $39.50 a share.

• Celgene Corporation (NASDAQ: CELG) - Celegene is one of the brightest stars among large-cap biotech stocks focusing on treatments for cancer and other inflammatory conditions. It’s trading at PEG ratio of 0.99 and a forward P/E of 18.18. BUY Under $60.00 a share.

• B

Regards,

Don